112 AUA 5 12

7:00 16 000

1 AUA
12 8000

Podium
AUA

2 podium
Podium
ILND
n = 175n = 28 203
 ILN
ILCS ILNs 5 /
/ Clavien-Dindo Logistic
ILCS 2 OR
ILC ILND

3 8

10 TCGA
8 236
TCGA COX 12
qRT-PCR
AUC AUC=0.727
AUC=0.631 PD-L1

4

110 FTO SNP FTO
FTO
FTO RNA-SEQ FTO
FTO
FTO NF-
KB
 5
Bladder CancerBasic Research & Pahthophysiology I

Identification
and validation of C1orf198 as an independent marker of bladder cancer
metastasis in SEER and TCGA database SEER
TCGA

6
Kidney Cancer: Basic Research & Pathophysiology III
Tumor Infiltrating Mast Cells
(TIMs) Confers a Marked Survival Advantage in Non-Metastasis Clear-Cell
Renal Cell CarcinomaMP73-04
T Fuhrman

 7 1HP1

Kidney Cancer: Epidemiology
& Evaluation/Staging IIIncreased Hp1-gamma
expression associates with adverse outcome in patients with non-metastatic
clear cell renal cell carcinomaMP67-02
1HP1

2016 3032 96%
8728

8
AUA AUA2017